Showing results (631-640 of 668) with videos related to

Sort By:
Pageof 67
Metallomics : Integrated Biometal Science|April 11, 2019
Zinc intoxication induces ferroptosis in A549 human lung cellsLauren D Palmer, Ashley T Jordan, K Nichole Maloney, et al.
The Journal of Biological Chemistry|October 4, 2013
Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cellsShanshan Pei, Mohammad Minhajuddin, Kevin P Callahan, et al.
American Journal of Human Genetics|April 24, 2012
PSORS2 is due to mutations in CARD14Catherine T Jordan, Li Cao, Elisha D O Roberson, et al.
Cell Stem Cell|August 22, 2020
Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem CellsCourtney L Jones, Brett M Stevens, Daniel A Pollyea, et al.
The Journal of Infectious Diseases|September 24, 2008
Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illnessNicholas D Walter, Gavin B Grant, Utpala Bandy, et al.
The Journal of Experimental Medicine|April 15, 2021
PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stressJames S Chavez, Jennifer L Rabe, Dirk Loeffler, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial CalciumAnagha Inguva Sheth, Krysta Engel, Hunter Tolison, et al.
Haematologica|May 19, 2019
Pro-inflammatory cytokine blockade attenuates myeloid expansion in a murine model of rheumatoid arthritisGiovanny Hernandez, Taylor S Mills, Jennifer L Rabe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2021
Treatment for Brain Metastases: ASCO-SNO-ASTRO GuidelineMichael A Vogelbaum, Paul D Brown, Hans Messersmith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent GlioblastomaLakshmi Nayak, Annette M Molinaro, Katherine Peters, et al.
Pageof 67